> 0 1 0 1 O
60 2 4 2 4 B-lower_bound
mL 5 7 5 7 I-lower_bound
/ 7 8 7 8 I-lower_bound
min/1.73 8 16 8 16 I-lower_bound
m2 17 19 17 19 I-lower_bound
for 20 23 20 23 O
subjects 24 32 24 32 O
with 33 37 33 37 O
creatinine 38 48 38 48 B-clinical_variable
levels 49 55 49 55 I-clinical_variable
above 56 61 56 61 O
institutional 62 75 62 75 O
normal 76 82 76 82 O

AST 0 3 83 86 B-clinical_variable
( 4 5 87 88 I-clinical_variable
SGOT)/ALT 5 14 88 97 I-clinical_variable
( 15 16 98 99 I-clinical_variable
SGPT 16 20 99 103 I-clinical_variable
) 20 21 103 104 I-clinical_variable
< 22 23 105 106 O
2.5 24 27 107 110 B-upper_bound
X 28 29 111 112 I-upper_bound
institutional 30 43 113 126 I-upper_bound
upper 44 49 127 132 I-upper_bound
limit 50 55 133 138 I-upper_bound
of 56 58 139 141 I-upper_bound
normal 59 65 142 148 I-upper_bound

Age 0 3 149 152 B-age
of 4 6 153 155 O
18 7 9 156 158 B-lower_bound
years 10 15 159 164 I-lower_bound
or 16 18 165 167 O
older 19 24 168 173 O

HIV 0 3 174 177 B-chronic_disease
- 3 4 177 178 O
positive 4 12 178 186 O
individuals 13 24 187 198 O
on 25 27 199 201 O
combination 28 39 202 213 B-treatment
antiretroviral 40 54 214 228 I-treatment
therapy 55 62 229 236 I-treatment

History 0 7 237 244 O
of 8 10 245 247 O
anaphylactic 11 23 248 260 O
reaction 24 32 261 269 O
attributed 33 43 270 280 O
to 44 46 281 283 O
any 47 50 284 287 B-allergy_name
contrast 51 59 288 296 I-allergy_name
agent 60 65 297 302 I-allergy_name
or 66 68 303 305 O
drugs 69 74 306 311 B-allergy_name
containing 75 85 312 322 I-allergy_name
polyethylene 86 98 323 335 I-allergy_name
glycol 99 105 336 342 I-allergy_name
( 106 107 343 344 I-allergy_name
PEG 107 110 344 347 I-allergy_name
) 110 111 347 348 I-allergy_name

Pregnant 0 8 349 357 B-pregnancy
women 9 14 358 363 B-gender
or 15 17 364 366 O
lactating 18 27 367 376 O
women 28 33 377 382 O

Should 0 6 383 389 O
a 7 8 390 391 O
woman 9 14 392 397 B-gender
become 15 21 398 404 B-pregnancy
pregnant 22 30 405 413 I-pregnancy
or 31 33 414 416 O
suspect 34 41 417 424 O
she 42 45 425 428 O
is 46 48 429 431 O
pregnant 49 57 432 440 O
while 58 63 441 446 O
participating 64 77 447 460 O
in 78 80 461 463 O
this 81 85 464 468 O
study 86 91 469 474 O
, 91 92 474 475 O
she 93 96 476 479 O
should 97 103 480 486 O
inform 104 110 487 493 O
her 111 114 494 497 O
treating 115 123 498 506 O
physician 124 133 507 516 O
immediately 134 145 517 528 O

Subjects 0 8 529 537 O
at 9 11 538 540 O
any 12 15 541 544 O
cancer 16 22 545 551 B-cancer
stage 23 28 552 557 O
will 29 33 558 562 O
be 34 36 563 565 O
enrolled 37 45 566 574 O

Subjects 0 8 575 583 O
may 9 12 584 587 O
have 13 17 588 592 O
previously 18 28 593 603 O
received 29 37 604 612 O
pre 38 41 613 616 B-treatment
- 41 42 616 617 I-treatment
operative 42 51 617 626 I-treatment
radiation 52 61 627 636 I-treatment
therapy 62 69 637 644 I-treatment

Subjects 0 8 645 653 O
must 9 13 654 658 O
be 14 16 659 661 O
sufficiently 17 29 662 674 O
healthy 30 37 675 682 O
to 38 40 683 685 O
undergo 41 48 686 693 O
surgery 49 56 694 701 B-treatment
or 57 59 702 704 O
an 60 62 705 707 O
endoscopic 63 73 708 718 B-treatment
procedure 74 83 719 728 I-treatment

Subjects 0 8 729 737 O
must 9 13 738 742 O
have 14 18 743 747 O
histologically 19 33 748 762 O
or 34 36 763 765 O
cytologically 37 50 766 779 O
confirmed 51 60 780 789 O
esophageal 61 71 790 800 B-cancer
, 71 72 800 801 O
colorectal 73 83 802 812 B-cancer
or 84 86 813 815 O
pancreatic 87 97 816 826 B-cancer
adenocarcinoma 98 112 827 841 I-cancer
( 113 114 842 843 O
inclusive 114 123 843 852 O
of 124 126 853 855 O
high 127 131 856 860 O
grade 132 137 861 866 O
dysplasia 138 147 867 876 O
) 147 148 876 877 O
on 149 151 878 880 O
a 152 153 881 882 O
biopsy 154 160 883 889 B-treatment
prior 161 166 890 895 O
to 167 169 896 898 O
surgery 170 177 899 906 B-treatment
and 178 181 907 910 O
must 182 186 911 915 O
be 187 189 916 918 O
scheduled 190 199 919 928 O
for 200 203 929 932 O
surgical 204 212 933 941 B-treatment
resection 213 222 942 951 I-treatment

Subjects 0 8 952 960 O
previously 9 19 961 971 O
treated 20 27 972 979 O
with 28 32 980 984 O
systemic 33 41 985 993 B-treatment
therapies 42 51 994 1003 I-treatment
to 52 54 1004 1006 O
treat 55 60 1007 1012 O
cancer 61 67 1013 1019 B-cancer
, 67 68 1019 1020 O
such 69 73 1021 1025 O
as 74 76 1026 1028 O
neo 77 80 1029 1032 B-treatment
- 80 81 1032 1033 I-treatment
adjuvant 81 89 1033 1041 I-treatment
chemotherapy 90 102 1042 1054 I-treatment
or 103 105 1055 1057 O
hormonal 106 114 1058 1066 B-treatment
therapy 115 122 1067 1074 I-treatment

Subjects 0 8 1075 1083 O
who 9 12 1084 1087 O
are 13 16 1088 1091 O
sexually 17 25 1092 1100 O
active 26 32 1101 1107 O
and 33 36 1108 1111 O
not 37 40 1112 1115 B-contraception_consent
willing 41 48 1116 1123 I-contraception_consent
/ 48 49 1123 1124 I-contraception_consent
able 49 53 1124 1128 I-contraception_consent
to 54 56 1129 1131 I-contraception_consent
use 57 60 1132 1135 I-contraception_consent
medically 61 70 1136 1145 I-contraception_consent
acceptable 71 81 1146 1156 I-contraception_consent
forms 82 87 1157 1162 I-contraception_consent
of 88 90 1163 1165 I-contraception_consent
contraception 91 104 1166 1179 I-contraception_consent
upon 105 109 1180 1184 O
entering 110 118 1185 1193 O
the 119 122 1194 1197 O
study 123 128 1198 1203 O

Subjects 0 8 1204 1212 O
who 9 12 1213 1216 O
have 13 17 1217 1221 O
not 18 21 1222 1225 O
recovered 22 31 1226 1235 O
from 32 36 1236 1240 O
adverse 37 44 1241 1248 O
events 45 51 1249 1255 O
due 52 55 1256 1259 O
to 56 58 1260 1262 O
pharmaceutical 59 73 1263 1277 B-treatment
or 74 76 1278 1280 I-treatment
diagnostic 77 87 1281 1291 I-treatment
agents 88 94 1292 1298 I-treatment
administered 95 107 1299 1311 O
more 108 112 1312 1316 O
than 113 117 1317 1321 O
4 118 119 1322 1323 B-lower_bound
weeks 120 125 1324 1329 I-lower_bound
earlier 126 133 1330 1337 O

Subjects 0 8 1338 1346 O
with 9 13 1347 1351 O
ECOG 14 18 1352 1356 B-clinical_variable
performance 19 30 1357 1368 I-clinical_variable
status 31 37 1369 1375 I-clinical_variable
of 38 40 1376 1378 O
0 41 42 1379 1380 B-lower_bound
or 43 45 1381 1383 O
1 46 47 1384 1385 B-upper_bound

Subjects 0 8 1386 1394 O
with 9 13 1395 1399 O
QTc 14 17 1400 1403 B-clinical_variable
interval 18 26 1404 1412 I-clinical_variable
> 27 28 1413 1414 O
480ms 29 34 1415 1420 B-lower_bound

Subjects 0 8 1421 1429 O
with 9 13 1430 1434 O
uncontrolled 14 26 1435 1447 B-chronic_disease
hypertension 27 39 1448 1460 I-chronic_disease
defined 40 47 1461 1468 O
as 48 50 1469 1471 O
persistent 51 61 1472 1482 O

Women 0 5 1483 1488 B-gender
of 6 8 1489 1491 O
child 9 14 1492 1497 O
- 14 15 1497 1498 O
bearing 15 22 1498 1505 O
potential 23 32 1506 1515 O
must 33 37 1516 1520 O
agree 38 43 1521 1526 B-contraception_consent
to 44 46 1527 1529 I-contraception_consent
use 47 50 1530 1533 I-contraception_consent
adequate 51 59 1534 1542 I-contraception_consent
contraception 60 73 1543 1556 I-contraception_consent
( 74 75 1557 1558 O
hormonal 75 83 1558 1566 B-contraception_consent
or 84 86 1567 1569 I-contraception_consent
barrier 87 94 1570 1577 I-contraception_consent
method 95 101 1578 1584 I-contraception_consent
of 102 104 1585 1587 I-contraception_consent
birth 105 110 1588 1593 I-contraception_consent
control 111 118 1594 1601 I-contraception_consent
, 118 119 1601 1602 O
abstinence 120 130 1603 1613 B-contraception_consent
) 130 131 1613 1614 O
starting 132 140 1615 1623 O
the 141 144 1624 1627 O
day 145 148 1628 1631 O
entering 149 157 1632 1640 O
the 158 161 1641 1644 O
study 162 167 1645 1650 O
, 167 168 1650 1651 O
and 169 172 1652 1655 O
for 173 176 1656 1659 O
60 177 179 1660 1662 B-upper_bound
days 180 184 1663 1667 I-upper_bound
after 185 190 1668 1673 I-upper_bound
injection 191 200 1674 1683 B-treatment
of 201 203 1684 1686 I-treatment
the 204 207 1687 1690 I-treatment
imaging 208 215 1691 1698 I-treatment
agent 216 221 1699 1704 I-treatment

inclusive 0 9 1705 1714 O
of 10 12 1715 1717 O
endoscopic 13 23 1718 1728 B-treatment
mucosal 24 31 1729 1736 I-treatment
resection 32 41 1737 1746 I-treatment
, 41 42 1746 1747 O
of 43 45 1748 1750 O
the 46 49 1751 1754 O
primary 50 57 1755 1762 B-cancer
tumor 58 63 1763 1768 I-cancer

systolic 0 8 1769 1777 B-clinical_variable
blood 9 14 1778 1783 I-clinical_variable
pressure 15 23 1784 1792 I-clinical_variable
> 24 25 1793 1794 O
180 26 29 1795 1798 B-lower_bound
mm 30 32 1799 1801 I-lower_bound
Hg 33 35 1802 1804 I-lower_bound
, 35 36 1804 1805 O
or 37 39 1806 1808 O
diastolic 40 49 1809 1818 B-clinical_variable
blood 50 55 1819 1824 I-clinical_variable
pressure 56 64 1825 1833 I-clinical_variable
> 65 66 1834 1835 O
110 67 70 1836 1839 B-lower_bound
mm 71 73 1840 1842 I-lower_bound
Hg 74 76 1843 1845 I-lower_bound

those 0 5 1846 1851 O
subjects 6 14 1852 1860 O
with 15 19 1861 1865 O
known 20 25 1866 1871 O
HTN 26 29 1872 1875 B-chronic_disease
should 30 36 1876 1882 O
be 37 39 1883 1885 O
under 40 45 1886 1891 O
these 46 51 1892 1897 O
values 52 58 1898 1904 O
while 59 64 1905 1910 O
under 65 70 1911 1916 O
pharmaceutical 71 85 1917 1931 B-treatment
therapy 86 93 1932 1939 I-treatment

total 0 5 1940 1945 B-clinical_variable
bilirubin 6 15 1946 1955 I-clinical_variable
within 16 22 1956 1962 O
normal 23 29 1963 1969 O
institutional 30 43 1970 1983 O
limits 44 50 1984 1990 O
( 51 52 1991 1992 O
except 52 58 1992 1998 O
in 59 61 1999 2001 O
cases 62 67 2002 2007 O
of 68 70 2008 2010 O
malignant 71 80 2011 2020 O
biliary 81 88 2021 2028 B-chronic_disease
obstruction 89 100 2029 2040 I-chronic_disease
) 100 101 2040 2041 O

ubjects 0 7 2042 2049 O
who 8 11 2050 2053 O
have 12 16 2054 2058 O
taken 17 22 2059 2064 O
an 23 25 2065 2067 O
investigational 26 41 2068 2083 B-treatment
drug 42 46 2084 2088 I-treatment
within 47 53 2089 2095 O
30 54 56 2096 2098 B-upper_bound
days 57 61 2099 2103 I-upper_bound
of 62 64 2104 2106 O
enrollment 65 75 2107 2117 O

